Skip to main content

Scientists Elucidate How DREADD Technology Highjacks Neuronal Activity

December 8, 2022

The Bryan Roth lab got some nice press for their recent Nature paper, revealing structural details of his chemogenetic technology called DREADD – designer receptors exclusively activated by designer drugs – that recognize drug-like but physiologically inert compounds. Postdoc Shicheng Zhang, PhD, led this research published in Nature.

Congratulations to our new PhD, Emily Fennell!

November 30, 2022

Dr. Fennell defended her thesis, “Profiling the Multi-omic Response to Mitochondrial Protease ClpP Activation in Triple-Negative Breast Cancer Cells,” November 22!